drugset / Trial / NCT00549666

A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects

NCT00549666

Phase 1 Completed 23 enrolled Sumitomo Pharma America, Inc.
RandomizedCrossoverDouble-blind

Summary

A Phase 1, drug, drug, interaction study between Lurasidone HCl and Ortho-tri cyclen

Timeline

Start
2007-08
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Lurasidone Small molecule 40 mg
Comparator Ortho Tri-Cyclen Unknown

Indications

No indication recorded.